About
Technology
Issues
FAQ
Links
Official Page
Tyrosine kinase inhibitor acquired resistance mechanism alternates between EGFR and ALK in a lung adenocarcinoma patient
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.